Markets:

Overview

News

Currencies

International

Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

6.195 -0.075 (-1.20%)

Streaming Delayed Price Updated: 1:06 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Ardelyx, Inc. Reports Employment Inducement Grants

May 14, 2024

From Ardelyx, Inc.

Via GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference

May 07, 2024

From Ardelyx, Inc.

Via GlobeNewswire

(ARDX) - Analyzing Ardelyx's Short Interest ↗

May 06, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 03, 2024

Via Benzinga

A Closer Look at 6 Analyst Recommendations For Ardelyx ↗

April 05, 2024

Via Benzinga

Where Ardelyx Stands With Analysts ↗

February 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 03, 2024

Via Benzinga

Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗

May 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 03, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 03, 2024

Pre-market stock movers are worth checking out this morning as we dive into all of the biggest news moving shares on Friday!

Via InvestorPlace

Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

May 03, 2024

Via Benzinga

ARDX Stock Earnings: Ardelyx Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

ARDX stock results show that Ardelyx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 02, 2024

Via Benzinga

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

May 02, 2024

From Ardelyx, Inc.

Via GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

May 01, 2024

From Ardelyx, Inc.

Via GlobeNewswire

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

April 18, 2024

Conference call scheduled for 4:30 p.m. Eastern Time

From Ardelyx, Inc.

Via GlobeNewswire

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 05, 2024

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Via Benzinga

Ardelyx, Inc. Reports Employment Inducement Grants

March 28, 2024

From Ardelyx, Inc.

Via GlobeNewswire

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

March 25, 2024

From Ardelyx, Inc.

Via GlobeNewswire

The Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter ↗

March 16, 2024

Explore why these stocks may explode and could be game-changers in biotechnology, hotels, resorts, cruise lines, and application software.

Via InvestorPlace

Ardelyx, Inc. Reports Employment Inducement Grants

March 12, 2024

From Ardelyx, Inc.

Via GlobeNewswire

The Millionaire’s Watchlist: 3 Stocks Set for a Meteoric Rise ↗

February 28, 2024

From biotechnology to digital tech endeavors, these stocks offer huge promise for the future, making them stocks to buy now.

Via InvestorPlace

Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS

February 28, 2024

Via AB Newswire

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

February 27, 2024

From Ardelyx, Inc.

Via GlobeNewswire

Stocks on the Launchpad: The Next 3 Market Sensations ↗

February 27, 2024

Navigate the bullish trend in the market by wagering on these three enticing market sensations likely to become multi-bagger investments

Via InvestorPlace

What's Going On With Ardelyx Stock After Earnings? ↗

February 23, 2024

Ardelyx reported ending 2023 with $184.3 million in cash and investments and expects full-year 2024 U.S. net product sales revenue for Ibsrela to be between $140 million and $150 million. Wedbush...

Via Benzinga

Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket ↗

February 23, 2024

Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 23, 2024

Via Benzinga

Ardelyx Posts Q4 Loss, Joins MercadoLibre, Booking Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 23, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 25 points on Friday.

Via Benzinga

Topics Stocks

Ardelyx Reports Mixed Q4 Results: Earnings Miss, Revenue Beat ↗

February 22, 2024

Ardelyx reported quarterly losses of 12 cents per share which missed the analyst consensus estimate of losses of 10 cents by 20%. The company reported quarterly sales of $34.36 million, beating the...

Via Benzinga

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.